-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LxH+VtbeBYt1CtXb260nmusiRt1KYd6qqCOyJslgSfia0vcu2N8SpTUPKX5cU1j9
 lVrIKe9OD7DoSQnGzgHoHQ==

<SEC-DOCUMENT>0000927946-03-000274.txt : 20031230
<SEC-HEADER>0000927946-03-000274.hdr.sgml : 20031230
<ACCEPTANCE-DATETIME>20031230153220
ACCESSION NUMBER:		0000927946-03-000274
CONFORMED SUBMISSION TYPE:	NT 10-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030930
FILED AS OF DATE:		20031230
EFFECTIVENESS DATE:		20031230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		NT 10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		031077735

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>basform12b25.htm
<DESCRIPTION>NOTIFICATION OF LATE FILING
<TEXT>
<HTML>
<HEAD>
<Title>Form 12b-25 - Notification of Late Filing</title></head>
<BODY>

<hr noshade>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION</FONT></H1>

<TABLE align=right WIDTH=15% CELLPADDING=4 CELLSPACING=0 BORDER=1>
<TR>
<TD width=15%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>SEC FILE<BR>NUMBER:<BR>000-23357<br><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><br>CUSIP NUMBER:<br>717131-10-6</FONT></div>
</TD>
</TR>
</TABLE>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Washington, D.C. 20549</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><br><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form 12b-25</b><br>
<br>
<b>NOTIFICATION OF LATE FILING</b><BR>
</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<i>(Check One)</i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[X]&nbsp;&nbsp;Form 10-K
&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Form 20-F
&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Form 11-K
&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Form 10-Q
&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Form N-SAR
&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Form N-CSR
</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
For Period Ended:&nbsp;&nbsp;Septemer 30, 2003</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
[&nbsp;&nbsp;]&nbsp;&nbsp;Transition Report on Form 10-K<BR>
[&nbsp;&nbsp;]&nbsp;&nbsp;Transition Report on Form 20-F<BR>
[&nbsp;&nbsp;]&nbsp;&nbsp;Transition Report on Form 11-K<BR>
[&nbsp;&nbsp;]&nbsp;&nbsp;Transition Report on Form 10-Q<BR>
[&nbsp;&nbsp;]&nbsp;&nbsp;Transition Report on Form N-SAR</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
For the Transition Period Ended:</font></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<i>Read Instruction (on back page) Before Preparing Form. Please Print or Type.</i></font></P>

<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Nothing  in this form shall
be construed to imply that the Commission has verified any information contained
herein.</B> </FONT></P>

<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the notification relates to
a portion  of the  filing  checked  above,  identify  the  Item(s)  to which the
notification relates: </FONT></P>
<HR>
<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>PART I - REGISTRANT INFORMATION</b></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>BIOANALYTICAL SYSTEMS, INC.</U><BR>
Full Name of Registrant<BR>
<BR>
<U>Not Applicable</U><BR>
Former Name if Applicable<BR>
<BR>
<U>2701 Kent Avenue</U><BR>
Address of Principal Executive Office (Street and Number)<BR>
<BR>
<U>West Lafayette, IN  47906</U><BR>
City, State and Zip Code<BR>
</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>PART II - RULES 12b-25(b) AND (c)</b></font></P>

<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the subject report could not
be filed without  unreasonable effort or expense and the registrant seeks relief
pursuant to Rule  12b-25(b),  the following  should be completed.  (Check box if
appropriate)&nbsp;&nbsp;[X]</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The reasons described in reasonable detail in Part III of this form could not be
eliminated without unreasonable effort or expense;</font></P>



<PAGE>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The subject annual report,  semi-annual report,  transition report on Form 10-K,
Form 20-F,  Form 11-K, Form N-SAR or Form N-CSR, or portion  thereof,  will be filed on or before
the fifteenth  calendar day following  the  prescribed  due date; or the subject
quarterly  report of transition  report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date; and</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The accountant's  statement or other exhibit required by Rule 12b-25(c) has been
attached if applicable.
</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>PART III - NARRATIVE</b></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State below in reasonable detail
the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or
portion  thereof,  could  not  be  filed  within  the  prescribed  time  period.
</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bioanalytical Systems, Inc. (the
"Company") is unable to file its Form 10-K for the fiscal year ended September
30, 2003, within the prescribed time period without unreasonable effort and
expense. Specifically, the resignation of the Company's controller, which was
effective in the fourth quarter of 2003, and the resignation of the Company's
Chief Financial Officer in November 2003 have resulted in a disruption of the
Company's normal processes for preparing its Form 10-K. Although the Company has
appointed an interim Chief Financial Officer and has retained a consulting firm,
the loss of accounting personnel has prevented the Company from producing all of
the information required to be provided in the Form 10-K despite the Company's
best efforts. The Company is currently in the process of recruiting a new
controller and a new Chief Financial Officer.</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>PART IV - OTHER INFORMATION</b></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Name and telephone number of person to contact in regard to this notification</font></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=33%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Michael P. Silvon</U><br>
(Name)</font></div></td>

<TD width=33%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(765)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><br>
(Area Code)</font></div></td>

<TD width=33%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;497-5831&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><br>
(Telephone Number)</font></div></td>

</TR>
</TABLE>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Have all  other  periodic  reports  required  under  Section  13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s).<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[X]&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&nbsp;&nbsp;]&nbsp;&nbsp;No</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Is it anticipated that any significant  change in results of operations from the
corresponding  period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[&nbsp;&nbsp;]&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X]&nbsp;&nbsp;No</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made. </FONT></P>


<PAGE>


<hr>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>BIOANALYTICAL SYSTEMS, INC.</U><br>
(Name of Registrant as Specified in Charter)<br>
<br>
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.<br>
</font></P>

<TABLE WIDTH=80% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>

<TD width=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<br>
</FONT>
</TD>

<TD valign=top width=35%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Date:&nbsp;&nbsp;December 30, 2003<U></U>
</FONT>
</TD>

<TD valign=top width=45%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
By:&nbsp;&nbsp;<U>/s/&nbsp;&nbsp;Peter T. Kissinger&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Peter T. Kissinger<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Chairman of the Board, President<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
and Chief Executive Officer<br>
</FONT>
</TD>
</TR>
</TABLE>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
INSTRUCTION:&nbsp;&nbsp;The  form may be signed by an  executive  officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative&#146;s  authority  to sign on behalf of the  registrant  shall be
filed with the form. </FONT></P>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
<b>ATTENTION</b></font></P>

<P ALIGN=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1001).</b>
</font></P>

</BODY>
</HTML>


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
